Both in Pharmaceuticals
Larimar Therapeutics vs Emergent Biosolutions
Over the past year LRMR returned −52.7% and EBS returned −30.3%; their daily moves had a correlation of 0.07.
LRMR −52.7% EBS −30.3%Growth of $1, one year, split-adjusted
| Metric | LRMR | EBS |
|---|---|---|
| Price | $1.99 | $6.38 |
| Market cap | $206.2M | $327.1M |
| Today | −0.25% | −11.14% |
| 1 month | −47.8% | −9.1% |
| 6 months | −58.6% | −27.6% |
| Year to date | −47.9% | −48.4% |
| 1 year | −53.2% | −33.5% |
| Revenue growth (YoY) | — | +66.3% |
| Gross margin | — | 58.6% |
| Net margin | — | −76.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $156.3M | -$442.1M |
| Dividend yield | — | — |
| Volatility (60d) | 65.2% | 96.9% |
| Short % of float | 24.9% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).